Ziconotide: a new option for refractory pain
- PMID: 16845440
- DOI: 10.1358/dot.2006.42.6.973534
Ziconotide: a new option for refractory pain
Abstract
Ziconotide has been introduced as a new nonopioid treatment for chronic pain. Structurally, it is a peptide, the synthetic analog of the omega-conotoxin, derived from the marine snail, Conus magus. N-type voltage-sensitive calcium channels play a role in the transmission of nociceptive stimuli and also are involved in the release of neurotransmitters important in pain transmission. Ziconotide's therapeutic benefit derives from its potent and selective blockade of neuronal-type voltage-sensitive calcium channels. Blockade of the channels results in suppression of abnormal ectopic discharges from the injury site or the dorsal root ganglia, possibly resulting in decreased neuroplasticity, and decreased synaptic transmission that leads to the generation of chronic pain syndromes. The advantage of ziconotide is that tolerance does not occur, while disadvantages associated with ziconotide are the need for intrathecal administration and significant neurotoxicites associated with its use. When tested in clinical trials, ziconotide has been shown to have synergistic or additive value to the effect of morphine. Ziconotide, formerly known also as SNX- 111, represents a new class of agents, the N-type calcium channel blockers. These may represent another option for patients with refractory pain and refractory pain syndromes.
Similar articles
-
Ziconotide: can we use it in palliative care?Am J Hosp Palliat Care. 2005 Sep-Oct;22(5):369-74. doi: 10.1177/104990910502200510. Am J Hosp Palliat Care. 2005. PMID: 16225359 Review.
-
Ziconotide--a novel neuron-specific calcium channel blocker for the intrathecal treatment of severe chronic pain--a short review.Int J Clin Pharmacol Ther. 2006 Oct;44(10):478-83. doi: 10.5414/cpp44478. Int J Clin Pharmacol Ther. 2006. PMID: 17063978 Review.
-
Ziconotide: neuronal calcium channel blocker for treating severe chronic pain.Curr Med Chem. 2004 Dec;11(23):3029-40. doi: 10.2174/0929867043363884. Curr Med Chem. 2004. PMID: 15578997 Review.
-
Ziconotide for treatment of severe chronic pain.Lancet. 2010 May 1;375(9725):1569-77. doi: 10.1016/S0140-6736(10)60354-6. Epub 2010 Apr 21. Lancet. 2010. PMID: 20413151
-
[New medications; ziconotide].Ned Tijdschr Geneeskd. 2006 Nov 4;150(44):2427-8. Ned Tijdschr Geneeskd. 2006. PMID: 17131701 Dutch.
Cited by
-
Determination of related substances in disulfide-rich peptide ziconotide by establishing tandem mass spectrometry methods.J Pharm Anal. 2024 Oct;14(10):101037. doi: 10.1016/j.jpha.2024.101037. Epub 2024 Jul 2. J Pharm Anal. 2024. PMID: 39386004 Free PMC article.
-
Brown Spider (Loxosceles) Venom Toxins as Potential Biotools for the Development of Novel Therapeutics.Toxins (Basel). 2019 Jun 19;11(6):355. doi: 10.3390/toxins11060355. Toxins (Basel). 2019. PMID: 31248109 Free PMC article. Review.
-
Immobilized N-chlorosuccinimide as a friendly peptide disulfide-forming reagent.ACS Comb Sci. 2014 Apr 14;16(4):160-3. doi: 10.1021/co500003p. Epub 2014 Mar 31. ACS Comb Sci. 2014. PMID: 24641490 Free PMC article.
-
Natural products and ion channel pharmacology.Future Med Chem. 2010 May;2(5):731-44. doi: 10.4155/fmc.10.31. Future Med Chem. 2010. PMID: 21426200 Free PMC article. Review.
-
Marine microorganism-invertebrate assemblages: perspectives to solve the "supply problem" in the initial steps of drug discovery.Mar Drugs. 2014 Jun 30;12(7):3929-52. doi: 10.3390/md12073929. Mar Drugs. 2014. PMID: 24983638 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
